Furthermore, Ahmadian el al. demonstrated that Azilsartan, an AT1R antagonist, elevated apoptosis at least partially by increasing BAX mRNA expression in HepG2 hepatocellular carcinoma cells (Ahmadian et al., 2018[3]). Here, AGTR1 is linked to hepatocellular carcinoma.